ERBB2 and neoplasm: To further explore somatic mutations in luminal tumors (HER2 negative) from very young patients, we identified another 29 patients aged ≤35 years at diagnosis, who had data published in studies of tumor exome or genome sequencing [15–18], most of which, deposited in the COSMIC database [15–17].